{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:16:19Z","timestamp":1761178579207,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.canrad.2021.08.021","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T20:33:49Z","timestamp":1635280429000},"page":"557-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35 Gy in 5 fractions"],"prefix":"10.1016","volume":"26","author":[{"given":"S.","family":"Sumodhee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kinj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Doyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"L\u2019Homel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Paquis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Almairac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hieronimus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Schiappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Sadoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sumodhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pontikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Richier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Hannoun-Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Scouarnec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-Y.","family":"Bondiau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.08.021_bib0150","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","article-title":"Guidelines for acromegaly management: an update","volume":"94","author":"Melmed","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2021.08.021_bib0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0889-8529(05)70059-1","article-title":"Pituitary surgery","volume":"28","author":"Laws","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.canrad.2021.08.021_bib0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3171\/2010.5.JNS091635","article-title":"Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes","volume":"114","author":"Sheehan","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.021_bib0165","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2010.7.FOCUS10153","article-title":"Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas","volume":"29","author":"Campbell","year":"2010","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.canrad.2021.08.021_bib0170","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2265.2006.02506.x","article-title":"Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas","volume":"64","author":"Minniti","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.canrad.2021.08.021_bib0175","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/EJE-09-1045","article-title":"Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit","volume":"162","author":"Roug","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.canrad.2021.08.021_bib0180","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2004.09.058","article-title":"Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients","volume":"62","author":"Colin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.021_bib0185","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1227\/NEU.0000000000001155","article-title":"Fractionated Stereotactic Radiotherapy for Pituitary Adenomas: Single-Center Experience in 75 Consecutive Patients","volume":"79","author":"Barber","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2021.08.021_bib0190","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3171\/2013.3.JNS12766","article-title":"Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study","volume":"119","author":"Sheehan","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.021_bib0195","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00701-007-1253-7","article-title":"Gamma knife radiosurgery for endocrine-inactive pituitary adenomas","volume":"149","author":"Lisc\u00e1k","year":"2007","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.canrad.2021.08.021_bib0200","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1227\/NEU.0b013e318222afed","article-title":"Long-term outcomes after gamma knife stereotactic radiosurgery for nonfunctional pituitary adenomas","volume":"69","author":"Park","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2021.08.021_bib0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3171\/2012.4.JNS112250","article-title":"Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism","volume":"117","author":"Starke","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.021_bib0210","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3171\/jns.2006.104.6.876","article-title":"Gamma surgery in the treatment of nonsecretory pituitary macroadenoma","volume":"104","author":"Mingione","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.021_bib0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jocn.2013.03.024","article-title":"Fractionated stereotactic radiosurgery using the Novalis system for the management of pituitary adenomas close to the optic apparatus","volume":"21","author":"Liao","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.canrad.2021.08.021_bib0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.wneu.2010.05.007","article-title":"Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas","volume":"74","author":"Tanaka","year":"2010","journal-title":"World Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.021_bib0225","doi-asserted-by":"crossref","first-page":"A19","DOI":"10.1227\/01.NEU.0000341630.42160.18","article-title":"Hypofractionated CyberKnife radiosurgery for perichiasmatic pituitary adenomas: early results","volume":"64","author":"Killory","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2021.08.021_bib0230","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/neuonc\/nor055","article-title":"Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity","volume":"13","author":"Iwata","year":"2011","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.canrad.2021.08.021_bib0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11060-016-2105-1","article-title":"Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus","volume":"128","author":"Iwata","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2021.08.021_bib0240","doi-asserted-by":"crossref","first-page":"NP10","DOI":"10.1177\/1533034615607113","article-title":"The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma","volume":"15","author":"Puataweepong","year":"2016","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.canrad.2021.08.021_bib0245","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2013-3743","article-title":"Stereotactic radiosurgery for acromegaly","volume":"99","author":"Lee","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2021.08.021_bib0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.wneu.2013.01.127","article-title":"Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report","volume":"82","author":"Grant","year":"2014","journal-title":"World Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.021_bib0255","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00066-014-0802-2","article-title":"Treatment of acromegaly patients with risk-adapted single or fractionated stereotactic high-precision radiotherapy: High local control and low toxicity in a pooled series","volume":"191","author":"Bostr\u00f6m","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2021.08.021_bib0260","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13014-016-0710-y","article-title":"Target delineation and optimal radiosurgical dose for pituitary tumors","volume":"11","author":"Minniti","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.08.021_bib0265","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3171\/jns.1984.61.5.0814","article-title":"A decade of pituitary microsurgery. The Herbert Olivecrona lecture","volume":"61","author":"Wilson","year":"1984","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2021.08.021_bib0270","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2013.06.2057","article-title":"Long-term outcomes of fractionated stereotactic radiation therapy for pituitary adenomas at the BC Cancer Agency","volume":"87","author":"Kim","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.021_bib0275","doi-asserted-by":"crossref","first-page":"482861","DOI":"10.1155\/2012\/482861","article-title":"Stereotactic Irradiation of GH-Secreting Pituitary Adenomas","volume":"2012","author":"Minniti","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.canrad.2021.08.021_bib0280","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11102-018-0868-4","article-title":"Management of nonfunctioning pituitary tumors: radiotherapy","volume":"21","author":"Minniti","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.canrad.2021.08.021_bib0285","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1227\/01.NEU.0000223512.09115.3E","article-title":"Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions","volume":"59","author":"Adler","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2021.08.021_bib0290","first-page":"284","article-title":"Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery","volume":"49","author":"H\u00f6ybye","year":"2001","journal-title":"Neurosurgery"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821002584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821002584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:35:38Z","timestamp":1761136538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821002584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1278321821002584"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.08.021","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35Gy in 5 fractions","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}